S3 Connected Health vs Phillips-Medisize: full comparison for 2026
Quick verdict
S3 Connected Health (4.2/5) edges ahead of Phillips-Medisize (3.9/5) overall. S3 Connected Health is the better choice for pharma companies adding connectivity to drug delivery. Phillips-Medisize is the stronger option for drug delivery devices needing high-volume production. The right choice depends on your project size, budget, and required tech stack.
S3 Connected Health vs Phillips-Medisize: head-to-head summary
| Criterion | S3 Connected Health | Phillips-Medisize |
|---|---|---|
| Founded | 2001 | 1964 |
| HQ | Dublin, Ireland | Hudson, WI, USA |
| Team size | 200–300 | ~7,000 |
| Rating | 4.2 / 5 | 3.9 / 5 |
| Primary differentiator | Combines embedded wireless engineering with patient-facing apps and data platforms for pharma programs | Design, molding and assembly of drug delivery devices under one global quality system |
| Pricing model | Fixed project, time and materials, managed service | Development contract plus manufacturing supply agreement |
| Min. engagement | Not disclosed | Not disclosed |
| Primary tech stack | BLE, Embedded C/C++, iOS | Injection molding, Automated assembly, BLE |
| Industries served | Drug delivery, Digital health, Wearables & remote monitoring | Drug delivery, Diagnostics & lab devices, Surgical & therapeutic devices |
S3 Connected Health vs Phillips-Medisize: overview
S3 Connected Health
S3 Connected Health is the connected health business of Dublin's S3 Group (Silicon & Software Systems), which dates to 1986; the connected health unit itself is listed as founded around 2001. After the group sold its semiconductor unit to Adesto, it concentrated on this business. It works with pharma and medtech companies on connected drug delivery, SaMD, IoMT platforms, wireless connectivity and data security, and partnered with Ypsomed on connected injection devices. Employee figures range from about 200 to 300.
Phillips-Medisize
Phillips-Medisize is a subsidiary of Molex, itself owned by Koch Industries, and provides outsourced design, development and manufacturing to pharma, diagnostics and medical device companies. It is based in Wisconsin and has about 7,000 employees. Molex's purchase of inhalation specialist Vectura added combination-product expertise, and the combined team includes more than 1,200 engineers and scientists across 30 sites. A $110M manufacturing campus in Katowice, Poland, opened in November 2023.
Services and capabilities: S3 Connected Health vs Phillips-Medisize
| Capability | S3 Connected Health | Phillips-Medisize |
|---|---|---|
| Electronics & PCB design | ✗ | ✓ |
| Firmware & embedded software | ✓ | ✗ |
| SaMD & companion apps | ✓ | ✗ |
| Connected devices & IoT | ✓ | ✗ |
| Industrial design & human factors | ✗ | ✗ |
| Mechanical engineering | ✗ | ✓ |
| Device cybersecurity | ✓ | ✗ |
| Regulatory & QMS support | ✓ | ✓ |
| Manufacturing & scale-up | ✗ | ✓ |
Tech stack comparison: S3 Connected Health vs Phillips-Medisize
| Framework / platform | S3 Connected Health | Phillips-Medisize |
|---|---|---|
| Embedded C/C++ | ✓ | N/A |
| Embedded Linux | N/A | N/A |
| RTOS | N/A | N/A |
| BLE | ✓ | ✓ |
| Cloud (AWS/Azure) | ✓ | N/A |
| IEC 62304 | ✓ | N/A |
| ISO 14971 | N/A | N/A |
| ISO 13485 QMS | N/A | ✓ |
| Qt | N/A | N/A |
Pricing comparison: S3 Connected Health vs Phillips-Medisize
| Criterion | S3 Connected Health | Phillips-Medisize |
|---|---|---|
| Minimum engagement | Not disclosed | Not disclosed |
| Engagement models | Dedicated team, Fixed project, Time & materials | Fixed project, Manufacturing contract |
| Rate transparency | Not public | Not public |
| Price tier | Mid-market | Mid-market |
Target audience comparison: S3 Connected Health vs Phillips-Medisize
| Dimension | S3 Connected Health | Phillips-Medisize |
|---|---|---|
| Best company size | Startup to mid-market | Startup to mid-market |
| Best industries | Drug delivery, Digital health, Wearables & remote monitoring | Drug delivery, Diagnostics & lab devices, Surgical & therapeutic devices |
| Best use cases | Adding Bluetooth connectivity to an autoinjector, Building a patient adherence app and backend | Autoinjector or pen injector development and production, Inhaler device for a pharma combination product |
| Typical project type | Dedicated team | Fixed project |
S3 Connected Health vs Phillips-Medisize: pros and cons
| S3 Connected Health | |
|---|---|
| + | Long experience in wireless and embedded software from its S3 Group background |
| + | Works directly with pharma on connected injectors and inhalers, such as the Ypsomed partnership |
| + | Covers apps, cloud and the device connectivity module |
| + | Delivery team includes a site in Poland, which helps with cost |
| - | Founding date and history are tangled with the wider S3 Group, so check which entity you contract with |
| - | Not a mechanical or industrial design firm |
| - | Pharma focus means pure medtech hardware projects are less common |
| Phillips-Medisize | |
|---|---|
| + | Very large manufacturing footprint across the US, Europe and Asia |
| + | Vectura deal added deep inhalation and combination-product skills |
| + | Development and manufacturing under one quality system |
| + | Experience with connected drug delivery |
| - | Owned by Molex and Koch Industries, so it suits large pharma more than small startups |
| - | Development work is usually tied to a manufacturing agreement |
| - | Less suited to software-heavy or early research projects |
Who should choose S3 Connected Health?
A typical fit: adding Bluetooth connectivity to an autoinjector.
Combines embedded wireless engineering with patient-facing apps and data platforms for pharma programs. Minimum engagement is not publicly disclosed. Works best with clients in Drug delivery, Digital health, Wearables & remote monitoring.
Who should choose Phillips-Medisize?
A typical fit: autoinjector or pen injector development and production.
Design, molding and assembly of drug delivery devices under one global quality system. Minimum engagement is not publicly disclosed. Works best with clients in Drug delivery, Diagnostics & lab devices, Surgical & therapeutic devices.
Decision matrix: S3 Connected Health vs Phillips-Medisize
| Your situation | Recommended choice |
|---|---|
| You need full-ownership delivery on a defined project scope | S3 Connected Health |
| You need a large dedicated team for an ongoing programme | S3 Connected Health |
| Your budget is at the lower end | Compare: S3 Connected Health (Not disclosed) vs Phillips-Medisize (Not disclosed) |
| You need specialist depth in a specific vertical | S3 Connected Health |
| You need staff augmentation or team extension | Neither; consider alternatives that offer staff aug |
| You need consulting before committing to a build | Both may offer discovery engagements |
Use case fit: S3 Connected Health vs Phillips-Medisize
| Use case | S3 Connected Health fit | Phillips-Medisize fit | Winner |
|---|---|---|---|
| Adding Bluetooth connectivity to an autoinjector | Strong | Limited | S3 Connected Health |
| Building a patient adherence app and backend | Strong | Limited | S3 Connected Health |
| Autoinjector or pen injector development and production | Strong | Strong | Both equally |
| Inhaler device for a pharma combination product | Limited | Strong | Phillips-Medisize |
Verdict: S3 Connected Health vs Phillips-Medisize
S3 Connected Health (4.2/5) is the stronger overall choice for most Medical Device Development projects. Combines embedded wireless engineering with patient-facing apps and data platforms for pharma programs.
Phillips-Medisize (3.9/5) is worth a look if you need inhaler device for a pharma combination product. If your situation matches that, Phillips-Medisize is a competitive option.
Related comparisons
S3 Connected Health vs Phillips-Medisize FAQ
Is S3 Connected Health better than Phillips-Medisize?
S3 Connected Health (4.2/5) scores higher overall, but "better" depends on your use case. S3 Connected Health's strongest advantage: long experience in wireless and embedded software from its S3 Group background. Phillips-Medisize's strongest advantage: very large manufacturing footprint across the US, Europe and Asia.
How do S3 Connected Health and Phillips-Medisize differ in pricing?
S3 Connected Health uses fixed project, time and materials, managed service pricing. Phillips-Medisize uses development contract plus manufacturing supply agreement pricing. Neither firm publishes a full rate card; a discovery call is required for project-specific quotes.
Which is better for enterprise: S3 Connected Health or Phillips-Medisize?
S3 Connected Health is the larger team and typically the better enterprise-scale choice. For very large programmes, verify team size and compliance coverage directly with each company before shortlisting.
What are the main differences between S3 Connected Health and Phillips-Medisize?
S3 Connected Health's primary differentiator is: combines embedded wireless engineering with patient-facing apps and data platforms for pharma programs. Phillips-Medisize's primary differentiator is: Design, molding and assembly of drug delivery devices under one global quality system. They also differ in team size (200–300 vs ~7,000), minimum engagement (Not disclosed vs Not disclosed), and primary industries served (Drug delivery, Digital health vs Drug delivery, Diagnostics & lab devices).
Verify all details directly with each company before making a decision.